Cargando…
Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
The Banff 2017 report permits the diagnosis of pure chronic antibody-mediated rejection (cAMR) in absence of microcirculation inflammation. We retrospectively investigated renal allograft function and long-term outcomes of 67 patients with cAMR, and compared patients who received antihumoral therapy...
Autores principales: | Wu, Kaiyin, Schmidt, Danilo, López del Moral, Covadonga, Osmanodja, Bilgin, Lachmann, Nils, Zhang, Qiang, Halleck, Fabian, Choi, Mira, Bachmann, Friederike, Ronicke, Simon, Duettmann, Wiebke, Naik, Marcel G., Schrezenmeier, Eva, Rudolph, Birgit, Budde, Klemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745558/ https://www.ncbi.nlm.nih.gov/pubmed/35011939 http://dx.doi.org/10.3390/jcm11010199 |
Ejemplares similares
-
Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions
por: Wu, Kaiyin, et al.
Publicado: (2022) -
The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022) -
A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
por: Mayrdorfer, Manuel, et al.
Publicado: (2022) -
Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016) -
Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022)